BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260505T160000
DTEND;TZID=Europe/London:20260505T170000
DTSTAMP:20260827T134959
CREATED:20260330T083139Z
LAST-MODIFIED:20260330T083139Z
UID:100119976-1777996800-1778000400@www.pathologynews.com
SUMMARY:Advancing Precision Medicine Through Pathology and AI-Powered CDx with Indica Labs
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar starts at 8:00 PDT\, 11:00 EDT\, 16:00 BST \nLearn about Indica Labs’ ability to deliver AI-driven CDx\n\n\nSummary\n\n\n\n\nJoin Indica Labs for an exciting webinar on developing AI-powered companion diagnostics in digital pathology. In this comprehensive session\, Indica Labs will introduce its vision for transforming bench to bedside to bench workflows\, take a deep dive into our experience in AI image analysis\, and demonstrate its ability to bring diagnostic products to market. Along the way\, you’ll learn about our experience conducting early proof-of-concept studies\, advancing them to biomarker discovery\, and managing clinical trial assays.   \nDon’t miss this opportunity to hear from senior executives as well as the CEO and Founder of Indica Labs on the topic of developing AI-driven companion diagnostics.  \n\n\nLearning Objectives\n\nLearn about Indica Labs’ initiatives and strategy for developing AI-powered CDx products in digital pathology\nGain insight into Indica Labs’ strategic partnership with Leica Biosystems\nDiscover how Indica Labs can take AI-based early proof-of–concept studies all the way through the development lifecycle to become a regulatory approved CDx\nFind out about deployment options in the CE-IVDR HALO AP® platform\nUnderstand the pathway to regulatory approval for CDx co-developed with Indica Labs and options for additional strategic partnerships\n\nHALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe\, the UK\, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition\, HALO AP® provides built-in compliance with FDA 21 CFR Part 11\, HIPAA\, and GDPR. \nRegister Now\nPresenters\n\nSteven Hashagen \nCEO and Founder\nIndica Labs  \nSteven Hashagen is the founder and CEO of Indica Labs\, a leading digital pathology software and AI company. Prior to forming Indica Labs in 2011\, Steven held software engineering\, software architect\, and product management roles at Aperio Technologies. Through this combined experience Steven has been a pioneer in the digital pathology field for over 20 years.  \nPeter Caie\, PhD\nSr. Director\, Precision Medicine\nIndica Labs \nPeter Caie worked for 9 years as a Senior Scientist at AstraZeneca before completing his PhD from the University of Edinburgh in Cancer Pathology. He went on to run the Quantitative and Digital Pathology (QUAD) Lab at the University of St Andrews where his research focused on artificial intelligence\, cancer prognosis and diagnosis in the field of digital and molecular pathology. Currently\, Dr. Caie is a Senior Director at Indica Labs where he manages the development of commercial AI products\, including CDx assays\, designed for deployment in both the clinical and life science fields.  \nDoug Bowman (Moderator)\nVP Precision Medicine\nIndica Labs  \nDoug is responsible for Indica Labs’ Precision Medicine group that partners with pharma companies to bring new AI-powered companion diagnostics to market. His team leads the commercial development of clinical AI solutions that deploy in HALO AP® and span laboratory operations to clinical research and diagnostic use cases. His Pharma Services team\, with deep experience in quantitative image analysis services\, supports customers’ pre-clinical and clinical biomarker assays. Prior to Indica Labs\, he spent 12+ years at Takeda Pharmaceuticals where he led the tissue-based imaging capabilities to support early discovery\, translational\, and clinical programs. Doug has a BSE in biomedical and electrical engineering from Duke University. 
URL:https://www.pathologynews.com/event/advancing-precision-medicine-through-pathology-and-ai-powered-cdx-with-indica-labs/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/03/Advancing-Precision-Medicine-Through-Pathology-and-AI-Powered-CDx-with-Indica-Labs.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260511T140000
DTEND;TZID=UTC:20260511T150000
DTSTAMP:20260827T134959
CREATED:20260423T092530Z
LAST-MODIFIED:20260423T092530Z
UID:100120535-1778508000-1778511600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series – Computational Pathology for Discovering Biomarkers of Immunotherapy Response in Advanced Melanoma
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Mark Schuiveling from UMC Utrecht\, the Netherlands. \nAbstract\nImmune checkpoint inhibition (ICI) has significantly improved outcomes for patients with advanced cutaneous melanoma\, leading to durable responses and potential long-term remission in approximately half of patients. However\, it is also associated with severe and sometimes irreversible toxicity\, underscoring the need for reliable biomarkers. In our group\, we investigate whether computational pathology approaches add value beyond clinical data for identifying biomarkers associated with treatment response in these patients. In this talk\, I will highlight our work on tumor-infiltrating lymphocytes in melanoma histopathology\, as well as our recent work in the PUMA challenge\, where we assessed whether additional immune cell subsets provide further associated predictive value. \nRegister NowBio\nMark Schuiveling is a medical doctor and PhD candidate at the University Medical Centre Utrecht\, the Netherlands. He is expected to defend his thesis in the summer of 2026 and is currently working as an internal medicine resident\, after which he will begin an oncology fellowship in 2027. His research focuses on melanoma\, in which he and his colleagues have assembled a multicentre dataset of digitized whole-slide images\, CT scans\, and clinical data\, with the aim of improving prediction of response to first-line immune checkpoint inhibition in patients with advanced melanoma. His work has primarily focused on histopathological analysis\, including tumor-infiltrating lymphocyte (TIL) assessment\, as well as on the organization of the PUMA challenge\, which investigated whether additional immune cell subtypes provide added predictive value.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-computational-pathology-for-discovering-biomarkers-of-immunotherapy-response-in-advanced-melanoma/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/04/TIA-Centre-Seminar-Series-Computational-Pathology-for-Discovering-Biomarkers-of-Immunotherapy-Response-in-Advanced-Melanoma.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260519T150000
DTEND;TZID=Europe/London:20260519T160000
DTSTAMP:20260827T134959
CREATED:20260427T102432Z
LAST-MODIFIED:20260427T151942Z
UID:100120617-1779202800-1779206400@www.pathologynews.com
SUMMARY:NPIC Digital Pathology Webinar Series - Innovation into Practice – NPIC Overview and Laboratory Implementation.​
DESCRIPTION:0000Days00Hrs00Min00SecThe National Pathology Imaging Co-Operative (NPIC)continues an exciting new series of free educational webinars on digital pathology topics. \n\nLearn first-hand about hot topics in clinical digital reporting\, the digital laboratory\, IT and informatics and get a chance to pose your questions to the experts! ​\nSuitable for pathologists\, biomedical scientists\, informatics and IT professionals\, managers and industry representatives.​\n\n​In this session:​​ \n\nGet an update of the NPIC national digital pathology PACS system in the NHS and the associated NPIC Secure Data Environment.​\nFind out how you can join NPIC and get involved.​\nLearn about digital implementation in the laboratory\, including practical considerations and tips for successful deployment.\n\nRegister NowPresenters\nProf Darren Treanor\nNPIC Programme Director\nNPIC\n\nShamila Jabbar\nNPIC Lead Biomedical Scientist\nNPIC\n\n\nDr Bethany Williams\nNPIC Knowledge and Skills Lead\nNPIC
URL:https://www.pathologynews.com/event/npic-digital-pathology-webinar-series-innovation-into-practice-npic-overview-and-laboratory-implementation/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/04/ChatGPT-Image-Apr-27-2026-at-03_31_22-PM.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260519T150000
DTEND;TZID=Europe/London:20260519T160000
DTSTAMP:20260827T134959
CREATED:20260507T084648Z
LAST-MODIFIED:20260514T082723Z
UID:100121016-1779202800-1779206400@www.pathologynews.com
SUMMARY:Two-part Webinar Series: Human Brilliance\, Augmented: Mastering Medical Information Overload with RAG and Second Brains. - Part 1
DESCRIPTION:0000Days00Hrs00Min00SecThis webinar will start at 3pm BST\, 10am EST \nIn this two-part webinar series\, Dr Soufiane Azdad and Dr Matthew Cecchini explore how AI is not here to replace the pathologist\, but to act as a powerful tool that augments human brilliance. \nEpisode 1 – The Cognitive Copilot: Taming Information Overload\nPart 1 – The Problem: Information Overload in Medicine \nThe exponential growth of medical literature\, complex classification updates\, and the cognitive load on practicing pathologists. Why generic LLMs fall short in clinical settings — hallucinations\, lack of source grounding\, and insufficient reliability for medical decision-making. \nPart 2 – Grounded AI: Retrieval-Augmented Generation at Scale \nPathology Outlines \nMyPathologyReport.com Osler \nBrief overview of NotebookLM as an accessible entry point for source-grounded AI. \nPart 3 – The Second Brain: Building a Living Knowledge Ecosystem \nThe second brain concept: moving beyond simple PDF querying to a comprehensive\, interconnected knowledge graph linking diagnoses\, IHC panels\, molecular testing\, and case notes. \nDemo of the daily workflow — capturing\, linking\, and retrieving knowledge at the point of need. \nLLM-KB-Wiki: the emerging approach (inspired by Andrej Karpathy) of giving an LLM the structured index of your knowledge base rather than traditional RAG. \nLocal LLM deployment via Ollama on Mac Studio (M4 Max\, 128GB) — guaranteed patient privacy\, zero-cost inference. \nMulti-agent systems interacting with customized wikis as a tailored diagnostic co-pilot. \n*All sessions will be presented in English. \nRegister NowSpeakers\nDr Soufiane Akdad & Dr Matthew Cecchini
URL:https://www.pathologynews.com/event/two-part-webinar-series-human-brilliance-augmented-mastering-medical-information-overload-with-rag-and-second-brains-part-1/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/05/Two-part-Webinar-Series-Human-Brilliance-Augmented-Mastering-Medical-Information-Overload-with-RAG-and-Second-Brains.-–-Part-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260519T160000
DTEND;TZID=Europe/London:20260519T170000
DTSTAMP:20260827T134959
CREATED:20260416T093638Z
LAST-MODIFIED:20260416T093638Z
UID:100120336-1779206400-1779210000@www.pathologynews.com
SUMMARY:Masterclass: Performing Spatial Analysis Workflows with HALO®
DESCRIPTION:0000Days00Hrs00Min00SecThe webinar will start at 8:00 PDT\, 11:00 EDT\, 16:00 BST \nLearn how to unlock deeper insights and enhance your data using the HALO Spatial Analysis module\nSummary\nThe HALO® Spatial Analysis module enables quantitative assessment of cellular spatial relationships within whole-slide images\, providing a clear and reproducible way to study spatial biology in brightfield and fluorescence tissue images and supporting richer\, more informative data outputs. Join Indica Labs for a masterclass exploring the key steps in a spatial analysis workflow: validating object data\, defining biologically relevant cell populations via filtering\, and generating interactive spatial plots. David Cordover\, Field Applications Scientist\, will discuss the algorithms included in the module—nearest neighbor\, proximity\, infiltration\, and density heatmaps—and demonstrate how they enable users to measure cell–cell distances\, assess spatial proximity within defined radii\, quantify cellular infiltration across tissue interfaces\, and visualize regional cell density patterns. \nDavid will also explore the Spatial Analysis module’s data visualization capabilities\, including customizable plot layers\, histograms\, color‑scaled heatmaps\, and markup images\, and walk through how they support both quality control and biological interpretation. Advanced features for saving and reusing spatial analysis settings\, batch processing across studies\, and exporting detailed summary metrics\, object‑level data\, plots\, and reports for downstream statistical analysis will also be highlighted. \n\n\nLearning Objectives\n\n\n\n\n\nLearn how to prepare and use cell and object data for spatial analysis in HALO \nRun and understand key spatial analysis tools\, including nearest neighbor\, proximity\, infiltration\, and density heatmaps\nView and adjust spatial results using plots and markup images \nRun analyses on multiple images\, save settings\, and export results for further use \n\n\n\nRegister Now\nPresenter\n\nDavid Cordover \nField Applications Scientist \nIndica Labs  \nDavid Cordover is a research field scientist with over 20 years of experience supporting research in large biopharma\, biotech\, and CRO organizations. His career spans roles at AMGEN\, Takeda\, Akoya Biosciences\, and small CRO’s specializing in histology and digital pathology. For most of his career he has focused on AI‑ and ML‑driven image analysis\, digital pathology\, and quantitative biomarker discovery. David has led high‑impact biomarker programs from preclinical research through IND stages\, working with multiple image analysis platforms and whole‑slide scanners\, including HALO AI\, Visiopharm\, and Akoya technologies. 
URL:https://www.pathologynews.com/event/masterclass-performing-spatial-analysis-workflows-with-halo/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2026/04/Masterclass-Performing-Spatial-Analysis-Workflows-with-HALO®.jpg
END:VEVENT
END:VCALENDAR